Evidence network for deaths_(OS)

1ATTRACTION-2 (Kang), 20172KEYNOTE-061 (PDL1 CPS>1), 2018 KEYNOTE-061 (all population), 20181JAVELIN Gastric 300, 20181CA184-162, 2017placebopaclitaxelirinotecanStandard of Care (SoC)nivolumab alonepembrolizumab aloneavelumab aloneIpilimumab (10 mg/kg)direct evidencenetwork meta-analysis
T vs. C placebopaclitaxelirinotecanStandard of Care (SoC)nivolumab alonepembrolizumab aloneavelumab aloneIpilimumab (10 mg/kg)
placebo---NANANANANANANA
paclitaxelNA---NANANANANANA
irinotecanNANA---NANANANANA
Standard of Care (SoC)NANANA---NANANANA
nivolumab aloneNANANANA---NANANA
pembrolizumab aloneNANANANANA---NANA
avelumab aloneNANANANANANA---NA
Ipilimumab (10 mg/kg)NANANANANANANA---

pathologies: 272,123,187 - treatments: 558 result logic